Zhejiang Conba Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001H86
CNY
4.73
0.04 (0.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
6,435.64
6,647.81
5,925.93
6,489.39
5,827.30
6,666.67
6,903.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,435.64
6,647.81
5,925.93
6,489.39
5,827.30
6,666.67
6,903.78
Raw Material Cost
3,169.06
2,925.96
2,557.90
2,678.87
2,143.17
1,817.64
1,780.32
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
905.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.85
37.43
50.58
74.23
124.93
152.26
94.98
Selling and Distribution Expenses
2,385.29
2,731.91
2,481.09
2,885.09
2,896.59
3,754.34
3,867.49
Other Expenses
24.87
22.79
12.06
10.42
4.20
1.12
-83.19
Total Expenditure (Excl Depreciation)
5,824.90
5,923.18
5,210.15
5,742.44
5,206.68
5,735.39
5,815.92
Operating Profit (PBDIT) excl Other Income
610.7
724.5999999999999
715.8
746.9
620.6
931.3
1087.9
Other Income
152.77
235.63
167.96
1,689.77
171.66
127.57
21.17
Operating Profit (PBDIT)
1,059.97
1,249.61
1,133.71
2,653.89
1,023.89
1,308.38
1,346.65
Interest
21.85
37.43
50.58
74.23
124.93
152.26
94.98
Exceptional Items
29.68
-151.73
-238.99
272.46
211.51
-817.42
57.52
Gross Profit (PBDT)
3,266.58
3,721.86
3,368.03
3,810.51
3,684.13
4,849.04
5,123.46
Depreciation
354.00
333.12
286.86
304.10
277.39
273.42
250.01
Profit Before Tax
713.81
727.32
557.28
2,548.02
833.08
65.28
1,059.18
Tax
121.59
92.97
129.89
391.13
216.45
221.50
212.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
622.42
591.57
358.12
2,017.46
453.30
-345.63
815.16
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
622.42
591.57
358.12
2,017.46
453.30
-345.63
815.16
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
35.94
83.15
102.00
118.31
95.90
74.11
7.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
658.35
674.72
460.12
2,135.77
549.20
-271.52
822.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,819.71
7,041.06
6,913.87
7,200.83
5,026.17
4,662.38
5,693.31
Earnings per share (EPS)
0.25
0.23
0.14
0.79
0.18
0.0
0.31
Diluted Earnings per share
0.25
0.23
0.14
0.79
0.18
0.0
0.31
Operating Profit Margin (Excl OI)
8.6%
10.24%
11.46%
10.17%
9.86%
13.61%
15.58%
Gross Profit Margin
16.59%
15.95%
14.24%
43.95%
19.06%
5.08%
18.96%
PAT Margin
9.67%
8.9%
6.04%
31.09%
7.78%
-5.18%
11.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -3.19% vs 12.18% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -2.42% vs 46.64% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -10.53% vs 5.00% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -41.71% vs -26.09% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Zhejiang Conba Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
6,435.64
0
6,435.64
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,435.64
0
6,435.64
Raw Material Cost
3,169.06
0
3,169.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
21.85
0
21.85
Selling and Distribution Expenses
2,385.29
0
2,385.29
Other Expenses
24.87
0.00
24.87
Total Expenditure (Excl Depreciation)
5,824.90
0
5,824.90
Operating Profit (PBDIT) excl Other Income
610.74
0.00
610.74
Other Income
152.77
0
152.77
Operating Profit (PBDIT)
1,059.97
0
1,059.97
Interest
21.85
0
21.85
Exceptional Items
29.68
0
29.68
Gross Profit (PBDT)
3,266.58
0
3,266.58
Depreciation
354.00
0
354.00
Profit Before Tax
713.81
0
713.81
Tax
121.59
0
121.59
Provisions and contingencies
0
0
0.00
Profit After Tax
622.42
0
622.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
622.42
0
622.42
Share in Profit of Associates
0
0
0.00
Minority Interest
35.94
0
35.94
Other related items
0.00
0.00
0.00
Consolidated Net Profit
658.35
0
658.35
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,819.71
0
6,819.71
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
8.60%
0%
0.00
8.60%
Gross Profit Margin
16.59%
0%
0.00
16.59%
PAT Margin
9.67%
0%
0.00
9.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 643.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.19% vs 12.18% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 65.84 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.42% vs 46.64% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 90.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -10.53% vs 5.00% in Dec 2023

Annual - Interest
Interest 2.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -41.71% vs -26.09% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.60%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023